Related Experiment Video
Updated: Jun 24, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current
Ozlem Soran1, Aarush Manchanda, Stephan Schueler
1Cardiovascular Institute, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA 15213, USA. soranzo@upmc.edu
Insights
Coronary artery bypass surgery and percutaneous coronary intervention offer revascularization for coronary artery disease. This review addresses conflicting data on their long-term efficacy in multivessel disease to improve patient care.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI) are established revascularization treatments for coronary artery disease (CAD).
- Conflicting data exist regarding the long-term efficacy of CABG versus PCI, particularly for patients with multivessel coronary artery disease (MVD).
- Current practice guidelines lack robust prospective, randomized data comparing CABG and PCI in the modern era for MVD.
Purpose of the Study:
- To address existing conflicts in data comparing CABG and PCI for MVD.
- To improve understanding of optimal invasive revascularization strategies for CAD patients.
- To provide an evidence-based perspective on managing MVD that may challenge current standards.
Main Methods:
- This is a review article synthesizing existing literature.
- The review critically analyzes available data on CABG and PCI outcomes.
- It focuses on patient subgroups with differing clinical characteristics (e.g., diabetes, left ventricular dysfunction).
Main Results:
- Long-term efficacy comparisons between CABG and PCI for MVD remain debated.
- Clinical outcomes are influenced by factors like the number of diseased vessels, diabetes, and left ventricular function.
- The clinical utility of the term 'multivessel disease' is questioned due to outcome variability.
Conclusions:
- Further high-quality, randomized trials are needed to definitively compare CABG and PCI in MVD.
- Personalized treatment strategies are essential for CAD patients based on individual risk factors.
- An updated understanding of MVD management may necessitate a shift from current standards of practice.
Abstract:
Coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI) are both safe and established treatment modalities of invasive revascularization for patients with coronary artery disease (CAD). However, conflicting information exists when comparing the long-term efficacy of the two methods. The optimal treatment for patients with multivessel coronary artery disease (MVD) is still subject to discussion, given the lack of fairly designed, prospective, randomized data reflecting current practice in the modern era. Furthermore, the clinical outcomes after invasive revascularization differ according to the number of diseased vessels, presence or absence of diabetes, left main disease and left ventricular dysfunction. Hence, the question arises whether we should continue to use the term 'multivessel disease'. Conflicts of available data need to be addressed and overcome so that care of patients with CAD can be successfully tailored. In this review article we try to address some of the above conflicts, in an effort to improve our understanding in the care of patients with multivessel disease. We also provide an evidence-based perspective which may differ from the current standard of practice.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
